title: Chronic nicotine and smoking treatment increases dopamine transporter mRNA expression in the rat midbrain.
abstract: Previous pharmacokinetics and electrophysiological results indicated an important role of nicotine in the modulation of dopamine transporter (DAT). To elucidate the expression changes of DAT on chronic nicotine and smoke administration, the effects of nicotine and passive cigarette smoke on DAT mRNA expression in the ventral tegmental area (VTA) and the substantia nigra (SN) area were examined using in situ hybridization and RNase protection assay. The results showed that chronic nicotine and smoke exposure highly unregulated DAT mRNA in the VTA and SN areas, including the dorsal part of substantia nigra pars compacta. Smoke for 30 min showed the highest increasing effect, whereas nicotine and smoke for 10 min only had slightly increasing effects. However, smoke for 1 h showed an increasing effect to a lesser extent than 30 min. These results revealed a new aspect of nicotine's modulation on the DAT, and may have important roles in neuropsychological disorders related to the midbrain abnormalities such as drugs addiction.
authors.affiliation: Division of Life Science and Applied Life Science (BK21), College of Natural Sciences, Gyeongsang National University, Gazwa-dong 900, Chinju, Gyeongnam, South Korea.
authors.forename: Shupeng
authors.initials: S
authors.lastname: Li
authors.forename: Kun Yang
authors.initials: KY
authors.lastname: Kim
authors.forename: Jong Hun
authors.initials: JH
authors.lastname: Kim
authors.forename: Jin Hoi
authors.initials: JH
authors.lastname: Kim
authors.forename: Moon Seok
authors.initials: MS
authors.lastname: Park
authors.forename: Jong Yoon
authors.initials: JY
authors.lastname: Bahk
authors.forename: Myeong Ok
authors.initials: MO
authors.lastname: Kim
mesh_terms: D000818:Animals; D001345:Autoradiography; D050483:Dopamine Plasma Membrane Transport Proteins; D004334:Drug Administration Schedule; D005786:Gene Expression Regulation / Q000187:drug effects*; D017403:In Situ Hybridization / Q000379:methods; D008297:Male; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins / Q000235:genetics / Q000378:metabolism*; D009419:Nerve Tissue Proteins / Q000235:genetics / Q000378:metabolism*; D009538:Nicotine / Q000008:administration & dosage*; D018722:Nicotinic Agonists / Q000008:administration & dosage*; D012333:RNA, Messenger / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D012907:Smoking / Q000378:metabolism*; D013378:Substantia Nigra / Q000187:drug effects* / Q000378:metabolism; D014158:Transcription, Genetic; D017557:Ventral Tegmental Area / Q000187:drug effects* / Q000378:metabolism
chemical_list: D050483:Dopamine Plasma Membrane Transport Proteins; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D018722:Nicotinic Agonists; D012333:RNA, Messenger; C493216:Slc6a3 protein, rat; D009538:Nicotine